EGFR but not PDGFR-β expression correlates to the antiproliferative effect of growth factor withdrawal in glioblastoma multiforme cell lines

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2315-2320

  Halatsch, Marc E ^a   Gehrke, Esther ^a   A Borhani, Farhad ^a   Efferth, Thomas ^b   Werner, Carola ^a   Nomikos, Panos ^a   Schmidt, Ursula ^a   Buchfelder, Michael ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Virtual Campus Rhineland Palatinate ^*  (Germany)

Author keywords

Epidermal growth factor receptor; Glioblastoma multiforme; Growth factor withdrawal; Platelet derived growth factor receptor ; Proliferation; Tumorigenicity

Indexed keywords

AGAR; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENICITY; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

CELL DIVISION; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041305055     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Filmus J, Pollak MN, Cairncross JG et al: Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line. Biochem Biophys Res Commun 131: 207-215, 1985.
2. Fischer U, Meltzer P and Meese E: Twelve amplified and expressed genes localized in a single domain in glioma, Hum Genet 98: 625-628, 1996.
3. Fong Y, Moldawer LL, Marano M et al: Cachectin/TNF or IL-1α induces cachexia with redistribution of body proteins. Am J Physiol 256: 659-665, 1989.
4. Halatsch M-E, Schmidt U, Bötefür IC et al: Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA. J Neurosurg 92: 297-305, 2000.
5. Halatsch M-E, Schmidt U, Bötefür IC et al: Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line. Anticancer Res 21: 189-196, 2001.
6. Halatsch M-E: Selective ribozyme-mediated inhibition of 801-bp deletion-mutant EGFR mRNA expression in human cancer-scan a war be won by killing one messenger? Signal 2: 12-16, 2001.
7. Hart CE, Bailey M, Curtis DA et al: Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. Biochemistry 29: 166-172, 1990.
8. Heldin C-H and Westermark B: Platelet-derived growth factor and autocrine mechanisms of oncogenic processes. Crit Rev Oncogen 2: 109-124, 1991.
9. Helseth E, Unsgaard G, Dalen A et al: The effects of type β transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma line. J Neuro-Oncol 6: 269-276, 1988.
10. Hermanson M, Funa K, Hartman M et al: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213-3219, 1992.
11. Huang H-JS, Nagane M, Klingbeil CK et al: The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 272: 2927-2935, 1997.
12. Jennings MT and Pietenpol JA: The role of transforming growth factor β in glioma progression. J Neuro-Oncol 36: 123-140, 1998.
13. Kawataki T, Naganuma H, Sasaki A et al: Correlation of thrombospondin-1 and transforming growth factor-β expression with malignancy of glioma. Neuropathology 20: 161-169, 2000.
14. Lang FF, Miller DC, Koslow M et al: Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81: 427-436, 1994.
15. Lieberman AP, Pitha PM, Shin HS et al: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86: 6348-6352, 1989.
16. Nagane M, Coufal F, Lin H et al: A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 56: 5079-5086, 1996.
17. Nishikawa R, Ji XD, Harmon RC et al: A mutant epidermal growth factor receptor common in human gliomas confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91: 7727-7731, 1994.
18. Nister M, Claesson-Welsh L, Eriksson A et al: Differential expression of PDGF receptors in human malignant glioma cell lines. J Biol Chem 266: 16755-16763, 1991.
19. Robbins DS, Shirazi Y, Drysdale BE et al: Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139: 2593-2597, 1987.
20. Rubin BY, Anderson SL, Sullivan SA et al: Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. J Exp Med 164: 1350-1355, 1986.
21. Schlegel J, Merdes A, Stumm G et al: Amplification of the epidermal growth factor receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56: 7277, 1994.
22. Su YA, Ray ME, Lin T et al: Reversion of monochromosome-mediated suppression of tumorigenicity in malignant melanoma by retroviral transduction. Cancer Res 56: 3186-3191, 1996.
23. Tang P, Steck PA and Yung WKA: The autocrine loop of TGFα/EGFR and brain tumors. J Neuro-Oncol 35: 303-314, 1997.
24. Uhrbom L, Hesslager G, Nister M et al: Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 58: 5275-5279, 1998.
25. Ullrich A and Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 202-212, 1990.
26. Van der Valk P, Lindeman J and Kamphorst W: Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma? Ann Oncol 8: 1023-1029, 1997.
27. Von Deimling A, Louis DN and Wiestler OD: Molecular pathways in the formation of gliomas. Glia 15: 328-338, 1995.
28. Weller M and Fontana A: The failure of current immunotherapy for malignant glioma: tumor-derived TGF-β, T-cell apoptosis, and the immune privilege of the brain. Brain Res 21: 128-151, 1995.
29. Wong AJ, Ruppert JM, Bigner SH et al: Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89: 2965-2969, 1992.
30. Yamazaki H, Ohba Y, Tamaoki N et al: A deletion mutation within the ligand-binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn J Cancer Res 81: 773-779, 1990.